0001209191-24-004948.txt : 20240319
0001209191-24-004948.hdr.sgml : 20240319
20240319174644
ACCESSION NUMBER: 0001209191-24-004948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spaventa Andrew
CENTRAL INDEX KEY: 0001859701
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40443
FILM NUMBER: 24765283
MAIL ADDRESS:
STREET 1: 10931 N. TORREY PINES ROAD, SUITE 100
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Singular Genomics Systems, Inc.
CENTRAL INDEX KEY: 0001850906
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 812948451
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3010 SCIENCE PARK ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 333-7830
MAIL ADDRESS:
STREET 1: 3010 SCIENCE PARK ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-03-15
0
0001850906
Singular Genomics Systems, Inc.
OMIC
0001859701
Spaventa Andrew
3010 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-03-15
4
M
0
14583
A
24349
D
Common Stock
2024-03-15
4
G
0
14583
0.00
D
9766
D
Common Stock
2024-03-15
4
G
0
14583
0.00
A
4090372
I
By The Andrew K. Spaventa Living Trust dated April 9, 2014
Common Stock
2569
I
By Axon Holdings, LLC
Restricted Stock Units
2024-03-15
4
M
0
14583
D
Common Stock
14583
175000
D
Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Immediately upon vesting of the Reporting Person's RSUs, the Reporting Person transferred his shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
Due to an administrative error, 2,569 shares were previously reported as distributed on March 24, 2022, but were not distributed. The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.
/s/ Dalen Meeter, Attorney-in-Fact
2024-03-19